Structural basis of the inhibition of TRPV1 by analgesic sesquiterpenes
Proceedings of the National Academy of Sciences · 2025
DOI: 10.1073/pnas.2506560122 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2025. Verfasst von Raúl Sánchez-Hernández und 11 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Neurociencia Cognitiva, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico. Hauptthemen laut MEDLINE: TRPV Cation Channels, Analgesics, Sesquiterpenes. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: HHS | National Institutes of Health (NIH), NINDS NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
The Transient Receptor Potential Vanilloid 1 (TRPV1) ion channel is expressed in primary nociceptive afferents, which participate in processes such as pain and inflammation. Considerable efforts have been directed toward finding inhibitors of TRPV1 and understanding the molecular details of their interactions with this channel. α-humulene (AH) is a sesquiterpene derived from plants such as hops and other members of Cannabaceae family, with a long history of popular use as an analgesic and anti-inflammatory. Using a combination of behavioral assays, electrophysiology, site-directed mutagenesis, cryo-EM, and molecular dynamics simulations, we show that AH inhibits TRPV1-related pain responses and currents by interacting with a region composed of the S2, S2-S3 linker, and S3 transmembrane segments and stabilizing the closed conformation of the channel. The interaction of ligands in this region of the TRPV1 channel has not been previously described and the results of the present study highlight that it may constitute part of a negative regulatory region. These findings allow us to understand the molecular basis by which substances such as some sesquiterpenes, abundantly found in medicinal plants used by humans for hundreds of years, reduce pain. Pain management can include the use of opioids, which results in hepatic and renal damage and possible addiction. Our study offers insight into a poorly understood group of compounds that could be used as scaffold to produce novel nonopioid analgesic therapies and clarifies the molecular mechanisms that underlie the effects of these analgesic molecules.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Neurociencia Cognitiva, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.
- Department of Biochemistry and Molecular Biophysics, Columbia University, New York, NY 10032.
- Department of Bioinformatics, Center for Bioinformatics, Simulation and Modeling, Faculty of Engineering, Universidad de Talca, Talca 3460000, Chile.
- Departamento de Neuropatología Molecular, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.
- Departamento de Fisiología, Facultad de Medicina, Universidad Nacional Autónoma de México, Mexico City 04510, Mexico.
- Laboratorio de Fisiología Celular, Dirección de Investigaciones en Neurociencias, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Mexico City 14370, Mexico.
ORCID-Profile: Raúl Sánchez-Hernández, Miguel Benítez-Angeles, Itzel Llorente, Francisco Mercado, Alexander I Sobolevsky, León D Islas, Tamara Rosenbaum
Förderung
- HHS | National Institutes of Health (NIH)
- NINDS NIH HHS
- NIGMS NIH HHS
- Consejo Nacional de Humanidades, Ciencias y Tecnologías (Conahcyt)
- UNAM | Dirección General de Asuntos del Personal Académico, Universidad Nacional Autónoma de México (DGAPA)
- ANID | Fondo Nacional de Desarrollo Científico y Tecnológico (FONDECYT)
- Agencia Nacional de Investigación y Desarrollo Doctoral Fellowship
- NIAMS NIH HHS
Zitieren
APA
Sánchez-Hernández, R., Benítez-Angeles, M., Talyzina, I. A., Llorente, I., González-Avendaño, M., Sierra, F., Méndez-Reséndiz, A., Mercado, F., Vergara-Jaque, A., Sobolevsky, A. I., Islas, L. D., & Rosenbaum, T. (2025). Structural basis of the inhibition of TRPV1 by analgesic sesquiterpenes. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2506560122
Vancouver
Sánchez-Hernández R, Benítez-Angeles M, Talyzina IA, Llorente I, González-Avendaño M, Sierra F, et al. Structural basis of the inhibition of TRPV1 by analgesic sesquiterpenes. Proceedings of the National Academy of Sciences. 2025. doi:10.1073/pnas.2506560122
BibTeX
@article{SnchezHernndez2025,
author = {Sánchez-Hernández, Raúl and Benítez-Angeles, Miguel and Talyzina, Irina A and Llorente, Itzel and González-Avendaño, Mariela and Sierra, Félix and Méndez-Reséndiz, Angélica and Mercado, Francisco and Vergara-Jaque, Ariela and Sobolevsky, Alexander I and Islas, León D and Rosenbaum, Tamara},
title = {Structural basis of the inhibition of TRPV1 by analgesic sesquiterpenes},
journal = {Proceedings of the National Academy of Sciences},
year = {2025},
doi = {10.1073/pnas.2506560122}
}
EUVIMED